Free Trial

Justin Bowers Analyst Performance

Analyst at Wells Fargo & Company

Justin Bowers is a stock analyst at Wells Fargo & Company across a range of sectors, covering 12 publicly traded companies. Over the past year, Justin Bowers has issued 17 stock ratings, including strong buy, buy, and hold recommendations. While full access to Justin Bowers' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Justin Bowers' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
18 Last 6 Years
Buy Recommendations
38.89% 7 Buy Ratings
Companies Covered
12 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy5.6%1 ratings
Buy33.3%6 ratings
Hold61.1%11 ratings
Sell0.0%0 ratings

Out of 18 total stock ratings issued by Justin Bowers at Wells Fargo & Company, the majority (61.1%) have been Hold recommendations, followed by 33.3% Buy and 5.6% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NYSE
50.0% of companies on NYSE
6 companies
NASDAQ
50.0% of companies on NASDAQ
6 companies

Justin Bowers, an analyst at Wells Fargo & Company, currently covers 12 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
6 companies
50.0%
Consumer Discretionary
5 companies
41.7%
Computer and Technology
1 company
8.3%

Justin Bowers of Wells Fargo & Company specializes in stock coverage within the Medical sector, with additional focus on Consumer Discretionary and Computer and Technology companies.

Coverage Industries

IndustryPercentage
GAMING
4 companies
33.3%
MED INSTRUMENTS
1 company
8.3%
MED/DENTAL - SUPP
1 company
8.3%
MEDICAL INFO SYS
1 company
8.3%
MED - BIOMED/GENE
1 company
8.3%
INTERNET CONTENT
1 company
8.3%
LEISURE&REC SVS
1 company
8.3%
MEDICAL SERVICES
1 company
8.3%
MED - HMO
1 company
8.3%

Justin Bowers' Ratings History at Wells Fargo & Company

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Waters Corporation stock logo
WAT
Waters
5/7/2026Reiterated Rating$351.07$350.00Hold
Waters Corporation stock logo
WAT
Waters
3/25/2026Lower Price Target$301.50$330.00Hold
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2/13/2026Reiterated Rating$242.88$315.00Buy
10x Genomics stock logo
TXG
10x Genomics
2/13/2026Set Price Target$19.27$17.00Hold
Bio-Techne Corp stock logo
TECH
Bio-Techne
12/12/2025Set Price Target$59.61$72.00Buy
Genius Sports Limited stock logo
GENI
Genius Sports
11/18/2025Initiated Coverage$9.45$10.00Equal Weight
Flutter Entertainment PLC stock logo
FLUT
Flutter Entertainment
11/18/2025Initiated Coverage$190.69$272.00Overweight
DraftKings Inc. stock logo
DKNG
DraftKings
11/18/2025Initiated Coverage$28.82$31.00Equal Weight
Churchill Downs, Incorporated stock logo
CHDN
Churchill Downs
11/18/2025Initiated Coverage$99.84$115.00Overweight
Caesars Entertainment, Inc. stock logo
CZR
Caesars Entertainment
11/18/2025Initiated Coverage$20.61$21.00Equal Weight
Boyd Gaming Corporation stock logo
BYD
Boyd Gaming
11/18/2025Initiated Coverage$77.53$85.00Equal Weight
DraftKings Inc. stock logo
DKNG
DraftKings
11/17/2025Upgrade$29.02Hold
Flutter Entertainment PLC stock logo
FLUT
Flutter Entertainment
11/17/2025Upgrade$193.38Strong-Buy
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10/24/2025Set Price Target$307.07$345.00Buy
10x Genomics stock logo
TXG
10x Genomics
8/8/2025Set Price Target$12.29$14.00Hold
Waters Corporation stock logo
WAT
Waters
8/5/2025Set Price Target$282.64$315.00Hold
Medpace Holdings, Inc. stock logo
MEDP
Medpace
7/23/2025Boost Price Target$456.14$430.00Hold